Barbara Oil Co’s Alder Biopharmaceuticals ALDR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-33,575
Closed -$633K 92
2019
Q3
$633K Hold
33,575
0.36% 70
2019
Q2
$395K Hold
33,575
0.23% 84
2019
Q1
$458K Hold
33,575
0.27% 75
2018
Q4
$344K Hold
33,575
0.23% 76
2018
Q3
$559K Hold
33,575
0.33% 78
2018
Q2
$530K Hold
33,575
0.34% 78
2018
Q1
$426K Hold
33,575
0.28% 81
2017
Q4
$384K Hold
33,575
0.25% 81
2017
Q3
$411K Hold
33,575
0.28% 82
2017
Q2
$384K Hold
33,575
0.28% 79
2017
Q1
$698K Hold
33,575
0.52% 61
2016
Q4
$698K Hold
33,575
0.54% 60
2016
Q3
$1.1M Hold
33,575
0.88% 39
2016
Q2
$838K Hold
33,575
0.67% 46
2016
Q1
$822K Hold
33,575
0.69% 48
2015
Q4
$1.11M Hold
33,575
0.93% 36
2015
Q3
$1.1M Buy
+33,575
New +$1.43M 0.97% 35

Barbara Oil Co's ALDR Position: Q4 2019 in Review

Barbara Oil Co sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 33,575 shares — an estimated $633K sold.

Barbara Oil Co first reported a position in ALDR in Q3 2015 and held it in 17 quarters. The position peaked at $1.11M in Q4 2015. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

  • Barbara Oil Co reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Barbara Oil Co sold 33,575 Alder Biopharmaceuticals shares in Q4 2019, an estimated $633K.
  • Barbara Oil Co first reported a position in Alder Biopharmaceuticals in Q3 2015 and held it in 17 quarters.
  • Barbara Oil Co's Alder Biopharmaceuticals position peaked at $1.11M in Q4 2015.
  • 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Barbara Oil Co's 13F filing for Q4 2019, filed 10 Feb 2020.